PEGylation of Antibody Fragments for Half-Life Extension
Author:
Publisher
Humana Press
Link
http://link.springer.com/content/pdf/10.1007/978-1-61779-931-0_15
Reference23 articles.
1. Liddell JM (2009) Production strategies for antibody fragment therapeutics. BioPharm Int 2:36–42
2. Labrijn AF, Aalberse RC, Schuurman J (2008) When binding is enough: nonactivating antibody formats. Curr Opin Immunol 20:479–485
3. Rader C (2009) Overview on concepts and applications of Fab antibody fragments. Curr Protoc Protein Sci. Chapter 6, 6.9.1–6.9.14
4. Chapman AP, Antoniw P, Spitali M et al (1999) Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol 17:780–783
5. Chen C, Constantinou A, Deonarain M (2011) Modulating antibody pharmacokinetics using hydrophilic polymers. Expert Opin Drug Deliv 8:1221–1236
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer;Journal of Controlled Release;2024-02
2. The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics;Chemical Reviews;2023-05-15
3. Development of an inhaled anti-TSLP therapy for asthma;Pulmonary Pharmacology & Therapeutics;2023-02
4. Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins;Molecules;2023-01-17
5. Developing a computational pharmacokinetic model of systemic snakebite envenomation and antivenom treatment;Toxicon;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3